Surgery Partners (SGRY) had the highest return between August 29, 2019 and November 30, 2019 by a mid-cap US stock, returning 116.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Surgery Partners (SGRY) | 8/29/2019 - 11/30/2019 | 116.33% |
Arrowhead Pharmaceuticals (ARWR) | 8/29/2019 - 11/30/2019 | 108.6% |
ADT (ADT) | 8/29/2019 - 11/30/2019 | 95.73% |
Synaptics (SYNA) | 8/29/2019 - 11/30/2019 | 80.83% |
Plug Power (PLUG) | 8/29/2019 - 11/30/2019 | 80.56% |
Centrus Energy (LEU) | 8/29/2019 - 11/30/2019 | 77.7% |
Palomar (PLMR) | 8/29/2019 - 11/30/2019 | 66.37% |
Tutor Perini (TPC) | 8/29/2019 - 11/30/2019 | 63.72% |
ACADIA Pharmaceuticals (ACAD) | 8/29/2019 - 11/30/2019 | 61.17% |
Signet Jewelers (SIG) | 8/29/2019 - 11/30/2019 | 59.62% |
89bio (ETNB) | 8/29/2019 - 11/30/2019 | 56.35% |
Axsome Therapeutics (AXSM) | 8/29/2019 - 11/30/2019 | 56.23% |
Align Technology (ALGN) | 8/29/2019 - 11/30/2019 | 55.41% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 8/29/2019 - 11/30/2019 | 55.37% |
Light & Wonder (LNW) | 8/29/2019 - 11/30/2019 | 55.37% |
BRP (DOOO) | 8/29/2019 - 11/30/2019 | 54.61% |
Cidara Therapeutics (CDTX) | 8/29/2019 - 11/30/2019 | 54.61% |
Crispr Therapeutics (CRSP) | 8/29/2019 - 11/30/2019 | 54.32% |
International Seaways (INSW) | 8/29/2019 - 11/30/2019 | 53.77% |
Newmark (NMRK) | 8/29/2019 - 11/30/2019 | 52.79% |
Crocs (CROX) | 8/29/2019 - 11/30/2019 | 49.72% |
Atkore International (ATKR) | 8/29/2019 - 11/30/2019 | 49% |
Qorvo (QRVO) | 8/29/2019 - 11/30/2019 | 47.27% |
Buckle (BKE) | 8/29/2019 - 11/30/2019 | 43.87% |
Box (BOX) | 8/29/2019 - 11/30/2019 | 43.51% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
